MIRA Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
MIRA Pharmaceuticals, Inc. (MIRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 546.67 thousand shares for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2025-03-28
- MIRA Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-09-30 was 120.00K shares.
- MIRA Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-06-30 was 275.00K shares.
- MIRA Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-03-31 was 151.67K shares.
- MIRA Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-12-31 was 0.00 shares.
- MIRA Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 170.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2024-09-30 | 120.00K shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-12 | 395.00K shares derived: sum of 2 quarters · filed 2024-11-12 | 546.67K shares 10-Q · filed 2024-11-12 | 546.67K shares derived: sum of 4 quarters · filed 2025-03-28 |
| 2024-06-30 | 275.00K shares derived: 10-Q/A 6 month − 10-Q 3 month · filed 2024-08-16 | 426.67K shares 10-Q/A · filed 2024-08-16 | 426.67K shares derived: sum of 3 quarters · filed 2025-03-28 | 426.67K shares derived: sum of 4 quarters · filed 2025-03-28 |
| 2024-03-31 | 151.67K shares 10-Q · filed 2024-05-13 | 151.67K shares derived: sum of 2 quarters · filed 2025-03-28 | 151.67K shares derived: sum of 3 quarters · filed 2025-03-28 | |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | 0.00 shares derived: sum of 2 quarters · filed 2025-03-28 | 170.00K shares 10-K · filed 2025-03-28 | |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 170.00K shares 10-Q · filed 2023-11-13 | ||
| 2023-06-30 | 170.00K shares 10-Q · filed 2023-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |